LIGHT
Lifescience Innovation Good Healthcare Technology (LIGHT) was born from the idea of the University of Brescia to expand (up to 1.800 m2) and modernize the spaces currently present in the laboratories of the CENTRO SERVIZI MULTISETTORIALE E TECNOLOGICO S.R.L. (CSMT) – controlled by the University itself – which represent a reference technological focal point created for the widespread growth of the territory, the stimulation of innovation and technology transfer and their application, and the development and improvement of the skills and competitiveness of companies. The infrastructure “LIGHT” will become a main centre for the development and transfer of technologies in the domain of health and wellbeing. Its main objective is to strengthen public private collaboration with a view to a more profound integration of basic research skills with industrial and experimental ones. The University of Brescia intends to enhance its research capacities through technology-driven multi-planning in the health sector and to improve the diagnosis, monitoring, assistance and rehabilitation care.
Some important private industrial companies with an international scope have manifested an expression of interest in the initiative and on specific research lines, an aspect that highlights the importance of the initiative and guarantees a rapid construction of the program, already extensively co-built with them. It will provide the international, national and local research community with high-grade instruments and services to conceive, experiment, develop and validate ideas in the fields of cutting-edge pharmacology coupled with artificial intelligence and of health tech for telemedicine and the hospital of the future.
“LIGHT” will promote the dissemination of technological innovation and will provide high-level competences, representing a point of interest for the national and international scientific community. The Infrastructure’s large-scale analytical and productivity capabilities will allow it to serve a very wide catchment area. Moreover, the research results will help to create new realities that will be able to convert ideas and research products into real products and services.
Objectives
The main trajectories that will characterize the infrastructure hubs will be the following:
AI and Big Data Main Hub
- Large scale analysis: integrative analysis on generated and remote acquired data
- Big data storage;
- Planning and design of a data sharing platform
- Web-site construction and updating
- Knowledge transfer management and Research doctorate coordination
Digital Health Care Hub
- Telemedicine, virtual care, digital technologies and sensors for preventive, participatory and personalized medicine and for the innovation of health services
- Hospital of the future, artificial intelligence for precision diagnostic, and clinical engineering for organizative innovation and management of health services;
- Advanced controls and comprehensive solutions in Track & Trace and Quality Inspection, to protect drugs throughout their life-cycle. Solutions for pharmaceutical production processes to ensure the best practices, to safeguard the future productions, to meet international compliance, to fight against counterfeiting, parallel productions and to protect the brand.
AI Biopharma Hub
- Artificial intelligence-driven design, synthesis and activity characterization of new drugs and bio-drugs through the Dompé EXCALATE platform
- Validation of the new drugs and peptide activity on potential pharmacological target in biological systems to generate new data feeding the database;
The infrastructure will be articulated according a multi-site model in the area of the University of Brescia North Campus (yellow, azure, blue and red areas). The Main Hub will host Big data, coordination and simulation, prototyping and experimentation activities with decentralized nodes. Below is the map relating to the expansion and modernization of the existing CSMT building (red highlighted area) structured in three floors, each 600 m2large (for a total of 1.800 m2): there will be the Main Hub offices and the experimental areas of the Digital Health care Hub (telemedicine, virtual care) with the in silico and molecular biology laboratories.